MarketScreener Strategies Lonza Group AG
Equities
LONN
CH0013841017
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 485.60 CHF | -1.18% |
|
-2.96% | -9.71% |
| 04/06 | Intron Health Downgrades Lonza Group to Sell, Cuts PT | MT |
| 12/05 | Swiss stocks - Factors to watch on May 12 | RE |
MarketScreener Strategies
Search
 | Lonza Group: Q1 commentary in line; 2026 guidance reaffirmed | May 08, 2026 at 05:50 pm IST |
 | Lonza Group: Ended 2025 on a high note | January 28, 2026 at 08:32 pm IST |
No results for this search
- Stock Market
- Equities
- LONN Stock
- News Lonza Group AG
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition